KM Financial Solutions | REFILE-UPDATE 1-North Carolina accuses drugmaker Insys of scheme to push opioid
6168
post-template-default,single,single-post,postid-6168,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

REFILE-UPDATE 1-North Carolina accuses drugmaker Insys of scheme to push opioid

REFILE-UPDATE 1-North Carolina accuses drugmaker Insys of scheme to push opioid

BOSTON, Dec 21 (Reuters) – North Carolina sued Insys
Therapeutics Inc on Thursday, accusing the
pharmaceutical company of illegally pushing a powerful
fentanyl-based cancer pain medicine called Subsys to boost
profits amid the U.S. opioid epidemic.

No Comments

Sorry, the comment form is closed at this time.